Breaking Finance News

Akzo Nobel N.V. (ADR) (NASDAQ:AKZOY) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.

Zacks Investment Research has upgraded Akzo Nobel N.V. (ADR) (NASDAQ:AKZOY) to Hold in a statement released on 09/20/2016.

Boasting a price of $22.43, Akzo Nobel N.V. (ADR) (NASDAQ:AKZOY) traded 0.31% higher on the day. With the last close up 0.85% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Akzo Nobel N.V. (ADR) has recorded a 50-day average of $22.31 and a two hundred day average of $22.24. Volume of trade was down over the average, with 22,915 shares of AKZOY changing hands under the typical 74,512

Performance Chart

Akzo Nobel N.V. (ADR) (NASDAQ:AKZOY)

Akzo Nobel N.V. (ADR) has a 52 week low of $18.73 and a 52 week high of $24.45 with a P/E ratio of 14.53 The company’s market cap is currently $0.

About Akzo Nobel N.V. (ADR) (NASDAQ:AKZOY)

Akzo Nobel N.V. is a paints and coatings company, and a producer of specialty chemicals. The Company operates in business areas, such as include Decorative Paints, Performance Coatings, Specialty Chemicals, and Corporate and other. Its Decorative Paints segment supplies a range of products, including paints, lacquers and varnishes. It also offers a range of mixing machines and color concepts for the building and renovation industry, as well as specialty coatings for metal, wood and other critical building materials. Its Performance Coatings segment has a portfolio, which includes paints and coatings for ships, yachts, cars, trucks and buses, industrial installations, structural steel, architectural components, beverage cans, furniture, aircraft, mobile devices and flooring. Its Specialty Chemicals segment supplies industries around the world with ingredients and process aids for the manufacture of life's essentials. Its brands include Coral, Dulux, Flexa, Sadolin, Sikkens and Bindzil.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *